官方服务：
资源简介：
transcirptome analyses reveal short-term response in osteosarcoma
应用场景：
创建时间：
2020-06-12
相关数据集
Identification of Anticarin-Ã target gene expression in human osteosarcoma cells
To gain insight into the Anticarin-Ã target gene profile in osteosarcoma cells, we performed RNA-seq analysis in MG63 cells upon CCT4 siRNA-mediated knockdown (siCCT4) or Anticarin-Ã. Overall desi
NIAID Data Ecosystem70
Expression data generated by full-length and truncated syndecan-1 overexpression in B6FS fibrosarcoma cell line. Homo sapiens
To dissect the functions of syndecan-1 in the nucleus, and separate them from functions related to the cell-surface, we transfected fibrosarcoma cells with two constructs: one encoding the full-length
NIAID Data Ecosystem60
Transcriptomic Analysis of Canine Osteosarcoma from a Precision Medicine Perspective Reveals Limitations of Differential Gene Expression Studies
Despite significant advances in cancer diagnosis and treatment, osteosarcoma (OSA), an aggressive primary bone tumor, has eluded attempts at improving patient survival for many decades. The difficulty
NIAID Data Ecosystem40
Full-length transcriptome sequencing reveals gene expression signatures in human soft tissue sarcomas. Full-length transcriptome sequencing reveals gene expression signatures in human soft tissue sarcomas
Soft tissue sarcomas (STSs) are heterogeneous malignancies derived from mesenchymal cells. Due to its rarity, heterogeneity, and limited overall response to chemotherapy, STSs represents a therapeutic
NIAID Data Ecosystem70
Transcriptome analysis of osteosarcoma cell lines treated with FDA-approved drugs
In order to understand the effect of FDA-approved drugs including doxorubicin (DOX) and HDACs inhibitors (PXD101 and PCI-24781) on osteosarcoma, 143B osteosarcoma cells were treated with the single ag
NIAID Data Ecosystem40
